New triple therapy could erase bladder tumors before surgery

NCT ID NCT06133517

First seen Mar 25, 2026 · Last updated Apr 28, 2026 · Updated 3 times

Summary

This study tests a combination of three drugs (sacituzumab govitecan, zimberelimab, and domvanalimab) given before and after bladder removal surgery for people with muscle-invasive bladder cancer who cannot take standard cisplatin chemotherapy. The main goal is to see if the treatment can completely eliminate the cancer by the time of surgery. About 70 adults will participate in this phase 2 trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL BLADDER CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clinico Universitario de Valladolid

    Valladolid, Valladolid, Spain

  • Hospital Clínico San Carlos

    Madrid, Madrid, Spain

  • Hospital Duran i Reynals (ICO L´Hospitalet)

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, Spain

  • Hospital Universitario de Navarra

    Pamplona, Navarre, Spain

  • Hospital Virgen de la Salud

    Toledo, Toledo, Spain

Conditions

Explore the condition pages connected to this study.